Literature DB >> 6428311

Effect of synthetic protease inhibitors of the amidine type on cell injury by Rickettsia rickettsii.

D H Walker, R R Tidwell, T M Rector, J D Geratz.   

Abstract

To evaluate the importance of proteolytic activity in the pathogenesis of cell injury by Rickettsia rickettsii, a series of four aromatic amidine inhibitors of trypsin-like proteases were introduced into the plaque model. The compounds were shown to be active toward plaque reduction with their order of effectiveness parallel to their antitrypsin activity. One of the compounds, bis(5-amidino-2-benzimidazolyl)-methane, at a concentration of 10(-5) M demonstrated complete inhibition of plaque formation on day 6. Bis(5-amidino-2-benzimidazolyl)methane at the same concentration reduced cell injury even when added to the system after 72 h of rickettsial infection. The reduction in morbidity in guinea pigs experimentally infected with R. rickettsii and treated with bis(5-amidino-2-benzimidazolyl)methane as compared with morbidity in infected, untreated animals, comprised delay in the onset of fever and slightly fewer febrile animals. Because bis(5-amidino-2-benzimidazolyl)methane had no effect on phospholipase A2, the enzyme activity associated with penetration-induced cell injury, it is likely that a trypsin-like protease also plays an essential role either in the physiology of R. rickettsii or as its pathogenic mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428311      PMCID: PMC185591          DOI: 10.1128/AAC.25.5.582

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Intracellular phospholipases A.

Authors:  H van den Bosch
Journal:  Biochim Biophys Acta       Date:  1980-09-30

2.  Mechanisms of inhibition of phospholipase A2.

Authors:  C Vigo; G P Lewis; P J Piper
Journal:  Biochem Pharmacol       Date:  1980-02-15       Impact factor: 5.858

3.  Amidino-substituted aromatic heterocycles as probes of the specificity pocket of trypsin-like proteases.

Authors:  J D Geratz; F M Stevens; K L Polakoski; R F Parrish; R R Tidwell
Journal:  Arch Biochem Biophys       Date:  1979-10-15       Impact factor: 4.013

4.  Fatal Rocky Mountain spotted fever.

Authors:  M A Hattwick; H Retailliau; R J O'Brien; M Slutzker; R E Fontaine; B Hanson
Journal:  JAMA       Date:  1978-09-29       Impact factor: 56.272

5.  Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane.

Authors:  E J Dubovi; J D Geratz; R R Tidwell
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

6.  Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.

Authors:  R R Tidwell; J D Geratz; O Dann; G Volz; D Zeh; H Loewe
Journal:  J Med Chem       Date:  1978-07       Impact factor: 7.446

7.  Studies of the rickettsial plaque assay technique.

Authors:  D A Wike; G Tallent; M G Peacock; R A Ormsbee
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

8.  Plaque formation in tissue cultures by Rickettsia rickettsi isolated directly from whole blood and tick hemolymph.

Authors:  D A Wike; W Burgdorfer
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

9.  Acute renal failure in Rocky Mountain spotted fever.

Authors:  D H Walker; W D Mattern
Journal:  Arch Intern Med       Date:  1979-04

10.  The rickettsial plaque. Evidence for direct cytopathic effect of Rickettsia rickettsii.

Authors:  D H Walker; B G Cain
Journal:  Lab Invest       Date:  1980-10       Impact factor: 5.662

View more
  10 in total

1.  Evidence for proteolytic cleavage of the 120-kilodalton outer membrane protein of rickettsiae: identification of an avirulent mutant deficient in processing.

Authors:  T Hackstadt; R Messer; W Cieplak; M G Peacock
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 2.  Rocky Mountain spotted fever: a disease in need of microbiological concern.

Authors:  D H Walker
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 3.  Comparative biology of intracellular parasitism.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1985-09

4.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

5.  Complementation of Rickettsia rickettsii RelA/SpoT restores a nonlytic plaque phenotype.

Authors:  Tina R Clark; Damon W Ellison; Betsy Kleba; Ted Hackstadt
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

6.  A Kunitz protease inhibitor from Dermacentor variabilis, a vector for spotted fever group rickettsiae, limits Rickettsia montanensis invasion.

Authors:  Shane M Ceraul; Ashley Chung; Khandra T Sears; Vsevolod L Popov; Magda Beier-Sexton; M Sayeedur Rahman; Abdu F Azad
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

7.  Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis.

Authors:  H M Feng; J Wen; D H Walker
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Mountain spotted fever.

Authors:  D J Silverman; L A Santucci
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Functional characterization and novel rickettsiostatic effects of a Kunitz-type serine protease inhibitor from the tick Dermacentor variabilis.

Authors:  Shane M Ceraul; Sheila M Dreher-Lesnick; Albert Mulenga; M Sayeedur Rahman; Abdu F Azad
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

Review 10.  Serine Protease Inhibitors in Ticks: An Overview of Their Role in Tick Biology and Tick-Borne Pathogen Transmission.

Authors:  Adrien A Blisnick; Thierry Foulon; Sarah I Bonnet
Journal:  Front Cell Infect Microbiol       Date:  2017-05-22       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.